Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 66376-36-1 |
MDL number | MFCD00868112 |
Molecular weight | 249.10 |
Molecular Formula | C4H13NO7P2 |
Product code | ICTA2120 |
PubChem Substance ID | 87560297 |
Purity/Analytical Methods | >98.0%(T) |
Reaxys-RN | 2275403 |
SDBS (AIST Spectral DB) | 52123 |
Appearance | White to Light yellow powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H314 : Causes severe skin burns and eye damage. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P260 : Do not breathe dusts or mists P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P303 + P361 + P353 : IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower P301 + P330 + P331 : IF SWALLOWED: Rinse mouth. Do NOT induce vomiting P363 : Wash contaminated clothing before reuse P304 + P340 + P310 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/doctor P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor P405 : Store locked up. |
Signal word | Danger |
RTECS# | SZ6521833 |
---|
Category | 8 |
---|---|
Packaging category | III |
UN number | UN1759 |
Chemicals by Class Compounds by Element Classes Phosphorous Compounds [Chemical Structural Class] Phosphonates [Chemical Structural Class] Phosphonic Acids & Phosphonic Acid Salts [Chemical Structural Class]
Life Science Biochemicals and Reagents Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Bone Resorption Inhibitors Cell Biology Cancer Research Cancer Metabolism Inhibitors of Mevalonate Pathway Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Bone Resorption Inhibitors